VARSITY: Vedolizumab showed superior Efficacy than that of Adalimumab in terms of clinical Remission and Mucosal Healing in Patients with moderate to severe active Ulcerative colitis

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2019年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [1] Vedolizumab is superior than Adalimumab in Patients with Ulcerative colitis
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (01):
  • [2] VARSITY: First Head-to-Head-Study in CED - Vedolizumab (Entyvio®) is superior to Adalimumab achieving clinical Remission and Mucosa Healing in adult Patients with ulcerative Colitis
    不详
    VISCERAL MEDICINE, 2019, 35 (03) : 198 - 198
  • [3] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Feagan, Brian G.
    Schreiber, Stefan
    Wolf, Douglas C.
    Axler, Jeffrey L.
    Kaviya, Arpeat
    James, Alexandra
    Curtis, Rebecca I.
    Geransar, Parnia
    Stallmach, Andreas
    Ehehalt, Robert
    Bokemeyer, Bernd
    Khalid, Javaria Mona
    O'Byrne, Sharon
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1028 - 1035
  • [4] Early Clinical Response and Remission With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY
    Danese, Silvio
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Peyrin-Biroulet, Laurent
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Schreiber, Stefan
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S421 - S421
  • [5] Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal B.
    GASTROENTEROLOGY, 2012, 142 (02) : 257 - +
  • [6] Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Van Assche, Gert A.
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert R.
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal
    GASTROENTEROLOGY, 2011, 140 (05) : S123 - S124
  • [7] Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Warner, Ben
    Harris, Adam W.
    GASTROENTEROLOGY, 2012, 143 (01) : E42 - E42
  • [8] Induction and maintenance of clinical remission by adalimumab in patients with moderate-to-severe Ulcerative Colitis
    Sandborn, William
    Van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas
    Kron, Martina
    Tighe, Mary
    Lazar, Andreas
    Thakkar, Roopal
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S3 - S4
  • [9] Current Data from the first Head-to-Head Study on Biologic Therapy in Ulcerative Colitis Patients Clinical Remission and Mucosal Healing in Adults: Vedolizumab superior to Adalimumab
    Thaesler, Elke
    VISCERAL MEDICINE, 2019, 35 (04) : 275 - 275
  • [10] VEDOLIZUMAB SHOWS SUPERIOR EFFICACY VERSUS ADALIMUMAB: RESULTS OF VARSITY-THE FIRST HEAD-TO-HEAD STUDY OF BIOLOGIC THERAPY FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Loftus, Edward V.
    Danese, Silvio
    Colombel, Jean Frederic
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Schreiber, Stefan
    GASTROENTEROLOGY, 2019, 156 (06) : S81 - S81
12345